Xevinapant plus radiotherapy in resected, high-risk, cisplatin-ineligible LA SCCHN: the phase III XRay Vision study design
Article in Future Oncology (January 2024)
The most recent citing publications are shown below. View all 103 publications that cite this research output on Dimensions.
Article in Future Oncology (January 2024)
Article in Scientific Reports (January 2024)
Preprint in Research Square (December 2023)